08/10/23 4:03 PMNasdaq : SIEN earningslow floatSientra Reports Record Second Quarter Financial and Operational ResultsRevenue growth of 7.5% driven by continued market share gains in reconstruction and augmentation Best operational results in company history with 95% and 63% year-over-year improvement in operating cash flow and adjusted EBITDA respectively Continued success in advancing products through the FDARHEA-AIneutral
07/27/23 4:05 AMNasdaq : SIEN conferencesearningslow floatSientra to Report Second Quarter 2023 Financial Results on August 10, 2023Sientra, Inc. (NASDAQ: SIEN)(“Sientra” or the “Company”), a medical aesthetics company developing the safest and most innovative solutions for the best aesthetic outcomes, today announced that it will release financial results for the secondRHEA-AIneutral
06/30/23 4:42 PMNasdaq : SIEN low floatSientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced that on June 27, 2023, the Company approved equity award grants under the Sientra Inc. Inducement Plan toRHEA-AIvery positive
06/20/23 8:35 AMNasdaq : SIEN managementlow floatSientra Announces Appointment of Alexander W. Casdin to Board of DirectorsSientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced the appointment of Alexander W. Casdin to the Company’s Board of Directors,RHEA-AIvery positive
06/08/23 4:05 PMNasdaq : SIEN low floatSientra Announces FDA-Clearance of Next Generation AlloX2 Pro™ Tissue ExpanderSientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medicalRHEA-AIpositive
05/17/23 8:30 AMNasdaq : SIEN low floatSientra Announces FDA-Clearance of Novel Portfinder™ TechnologySientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announcedRHEA-AIpositive
05/11/23 4:02 PMNasdaq : SIEN earningslow floatSientra Reports Record First Quarter 2023 Operational ResultsEleventh consecutive quarter of year-over-year growth, fueled by market outperformance in reconstruction Continued improvement in non-GAAP OPEX, adjusted EBITDA, and free cash flow performance demonstrating clear pathway to profitability DoubledRHEA-AIneutral
05/01/23 4:05 PMNasdaq : SIEN conferencesearningslow floatSientra to Report First Quarter 2023 Financial Results on May 11, 2023Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that it will release financial results for the first quarter of 2023 afterRHEA-AIneutral
03/30/23 4:02 PMNasdaq : SIEN low floatSientra Reports Record Fourth Quarter and Full Year Revenues and Expands Total Addressable Market With New Product LaunchesContinued 2+ year trend of consecutive record quarterly growth; fastest growing brand in the US breast market Disciplined cash management and enhanced operating leverage for 40% improvement in free cash flow results Significantly increased total addressable market with the launch of Viality™, aRHEA-AIneutral
03/20/23 8:35 AMNasdaq : SIEN conferencesearningslow floatSientra to Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that it will release financial results for the fourth quarter and fullRHEA-AIneutral